Creabilis SA

Quick facts

Phase 2 pipeline

• CT327 0.05% · Rheumatology
  CT327 is a selective inhibitor of 11β-HSD1.
• CT327 0.1%
• CT327 0.5% · Inflammation
  CT327 is a selective inhibitor of the 11β-HSD1 enzyme.
• CT327 ointment · Pain management
  CT327 ointment is a topical treatment that targets the cannabinoid receptor type 2 (CB2) to reduce inflammation and pain.